Smith, Moore & Co.
- SEC CIK
- 0000200724
- Latest filing
- Aug 12, 2026
MRK holding history
Merck & Co., Inc. in every 13F filed by Smith, Moore & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRK overviewAll 13F holders of MRKFull Q2 2026 holdings
- Shares (Q2 2026)
- 23,976
- Value
- $3.08M
- % of portfolio
- 0.2%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 23,976 | $3.08M | 0.2% | −1,997−7.7% | Reduced | Holders |
| Q1 2026 | 25,973 | $3.12M | 0.2% | −4,566−15.0% | Reduced | Holders |
| Q4 2025 | 30,539 | $3.21M | 0.2% | +6,925+29.3% | Added | Holders |
| Q3 2025 | 23,614 | $1.98M | 0.2% | +663+2.9% | Added | Holders |
| Q2 2025 | 22,951 | $1.82M | 0.2% | +452+2.0% | Added | Holders |
| Q1 2025 | 22,499 | $2.02M | 0.2% | −123−0.5% | Reduced | Holders |
| Q4 2024 | 22,622 | $2.25M | 0.2% | +485+2.2% | Added | Holders |
| Q3 2024 | 22,137 | $2.51M | 0.2% | +996+4.7% | Added | Holders |
| Q2 2024 | 21,141 | $2.62M | 0.3% | +1,389+7.0% | Added | Holders |
| Q1 2024 | 19,752 | $2.61M | 0.3% | −147−0.7% | Reduced | Holders |
| Q4 2023 | 19,899 | $2.17M | 0.3% | −109−0.5% | Reduced | Holders |
| Q3 2023 | 20,008 | $2.06M | 0.3% | −177−0.9% | Reduced | Holders |
| Q2 2023 | 20,185 | $2.33M | 0.3% | +874+4.5% | Added | Holders |
| Q1 2023 | 19,311 | $2.05M | 0.3% | −791−3.9% | Reduced | Holders |
| Q4 2022 | 20,102 | $2.23M | 0.3% | +729+3.8% | Added | Holders |
| Q3 2022 | 19,373 | $1.67M | 0.3% | −44−0.2% | Reduced | Holders |
| Q2 2022 | 19,417 | $1.77M | 0.3% | +2,578+15.3% | Added | Holders |
| Q1 2022 | 16,839 | $1.38M | 0.2% | +531+3.3% | Added | Holders |
| Q4 2021 | 16,308 | $1.25M | 0.2% | +1,008+6.6% | Added | Holders |
| Q3 2021 | 15,300 | $1.15M | 0.2% | +1,140+8.1% | Added | Holders |
| Q2 2021 | 14,160 | $1.10M | 0.2% | +1,548+12.3% | Added | Holders |
| Q1 2021 | 12,612 | $972.0K | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.